‘Can we do any better?’: Biomarkers, more data needed to reduce cytokine storm mortality

A more nuanced understanding of COVID-19-related cytokine storm syndrome may hold the key to minimizing fatalities, noted a presenter at the Basic and Clinical Immunology for the Busy Clinician symposium.
“This started from an early, data-deprived hypothesis that cytokine storm has a mechanistic basis of critical COVID-19 pathogenesis,” Puja Mehta, MD, a clinical research fellow in respiratory medicine at University College London, told attendees. “Given the success of immunomodulation, it is now widely accepted that a subgroup of patients with severe COVID-19 have a

A more nuanced understanding of COVID-19-related cytokine storm syndrome may hold the key to minimizing fatalities, noted a presenter at the Basic and Clinical Immunology for the Busy Clinician symposium.
“This started from an early, data-deprived hypothesis that cytokine storm has a mechanistic basis of critical COVID-19 pathogenesis,” Puja Mehta, MD, a clinical research fellow in respiratory medicine at University College London, told attendees. “Given the success of immunomodulation, it is now widely accepted that a subgroup of patients with severe COVID-19 have a